Allostery and Biased Agonism at Class B G Protein-Coupled Receptors
The DOI matches its Crossref record; 281 of the 281 references it cites were found in a registry or an index.
Abstract
Class B G protein-coupled receptors (GPCRs) respond to paracrine or endocrine peptide hormones involved in control of bone homeostasis, glucose regulation, satiety, and gastro-intestinal function, as well as pain transmission. These receptors are targets for existing drugs that treat osteoporosis, hypercalcaemia, Paget's disease, type II diabetes, and obesity and are being actively pursued as targets for numerous other diseases. Exploitation of class B receptors has been limited by difficulties with small molecule drug discovery and development and an under appreciation of factors governing optimal therapeutic efficacy. Recently, there has been increasing awareness of novel attributes of GPCR function that offer new opportunity for drug development. These include the presence of allosteric binding sites on the receptor that can be exploited as drug binding pockets and the ability of individual drugs to enrich subpopulations of receptor conformations to selectively control signaling, a phenomenon termed biased agonism. In this review, current knowledge of biased signaling and small molecule allostery within class B GPCRs is discussed, highlighting areas that have progressed significantly over the past decade, in addition to those that remain largely unexplored with respect to these phenomena.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As far as GIP is concerned, after binding its receptor on beta cells, GIP transduces its biological effects by increasing in cAMP and intracytoplasmic Ca2+ levels, in addition to the activation of PI3K, AKT, PKA, p38 MAP kinases and phospholipase A2 [41].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [41]
Citations
Cites
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
Ballesteros, J. A., & Weinstein, H. (1995) · Methods in Neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 2,999
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
Molecular signatures of G-protein-coupled receptors
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., & Babu, M. M. (2013) · Nature · doi:10.1038/nature11896 · Cited by 1,497
Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S., Chan, R., Turnbull, A. V., Lovejoy, D., Rivier, C., et al. (1995) · Nature · doi:10.1038/378287a0 · Cited by 1,479
CRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor
Kunishima, N., Shimada, Y., Tsuji, Y., Sato, T., Yamamoto, M., Kumasaka, T., Nakanishi, S., Jingami, H., & Morikawa, K. (2000) · Nature · doi:10.1038/35039564 · Cited by 1,249
Differential signal transduction by five splice variants of the PACAP receptor
Spongier, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburgt, P. H., & Journot, L. (1993) · Nature · doi:10.1038/365170a0 · Cited by 1,182
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
Vaudry, D., Falluel-Morel, A., Bourgault, S., Basille, M., Burel, D., Wurtz, O., Fournier, A., Chow, B. K. C., Hashimoto, H., Galas, L., et al. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001370 · Cited by 1,058
Lewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T. M., Gulyas, J., Fischer, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121165198 · Cited by 925
Research works printed but not linked: 7
- 10.1124/pr.114.009464 · DOI
- 10.3109/10606820213681 · doi:10.3109/10606820213681 · Paper page
- Yamamoto Y., 2006, Cell Mol. Biol. (Noisy-le-grand), 52, 25
- 10.1124/mol.112.079319 · DOI
- Frohman L. A., 2002, Minerva Endocrinol., 27, 277
- 10.1210/mend.13.12.0391 · doi:10.1210/mend.13.12.0391 · Paper page
- 10.1210/jcem.85.5.6590 · doi:10.1210/jcem.85.5.6590 · Paper page
Cited by
Items 101–117 of 117
A panoramic view on GPCRs: the 1st Berlin Symposium for Interdisciplinary GPCR research
Böck, A., & Bermúdez, M. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1513-5
Study of G protein coupling receptors
Sun, Y. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v66i.11708
“[14 ,16]”
Campbell, J. A., Do, P., Li, Z., Malik, F., Mead, C., Miller, N., Pisiechko, C., Powers, K., & Li, Z. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117864
Structure-function relationships in sensory G protein-coupled receptors
Razzaghi, N. (2022) · UPCommons institutional repository (Universitat Politècnica de Catalunya) · doi:10.5821/dissertation-2117-413885
The Receptors for CRF Peptides
Li, S., & Zhu, C. (2025) · Springer eBooks · doi:10.1007/978-981-96-5322-5_3
Wiseman, D. N. (2024) · Aston Publications Explorer (Aston University) · doi:10.48780/publications.aston.ac.uk.00047410
Kenakin, T., & Corsi, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00011-x
Physiopathologie de l’export de surface des récepteurs et transporteurs
Silva, E. D. (2023) · theses.fr (ABES) · doi:10.70675/62c3e228z16d6z4fe1za587zd8d5e2ee9c54
James-Okoro, P.-P., Field, J., Davies, G., Pearce, A., Al‐Sabah, S., Lim, K. N., Ladds, G., Hornigold, D. C., Gribble, F. M., & Reimann, F. (2026) · Peptides · doi:10.1016/j.peptides.2026.171507 · Cited by 1
Harikumar, K. G., Dengler, D. G., Roman, L. B., Ardecky, R., Sergienko, E. A., & Miller, L. J. (2026) · Membranes · doi:10.3390/membranes16070249
“…the data presented in the right panel of Figure 2 and Table 2 in which increasing concentrations of this compound modulated the biological activity of the natural full agonist, secretin, using the operational model of allosterism described in Kenakin and Christopoulos [23] and Wootten et al. [24].”
Self-citationZhou, X., Liu, M., Shi, Y., Duan, X., Gao, Y. H., & Han, W. (2026) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.70186
A new era of GPCR drug discovery: From receptor deorphanization to precision therapeutics
Komatsu, H. (2026) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.103.001
BindingDB Entry 50000599: Seeking (and Finding) Biased Ligands of the Kappa Opioid Receptor.
BindingDB (2019) · UC San Diego · doi:10.7270/q23n25tp
Metadata
- Authors
- Wootten, D., Miller, L. J., Koole, C., Christopoulos, A., & Sexton, P. M.
- Affiliations
- Monash University (AU)
- Mayo Clinic (US)
- Corresponding author
- Wootten, Denise
- Miller, Laurence J.
- Sexton, Patrick M.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-04-04
- Volume
- 117
- Issue
- 1
- Pages
- 111-138
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2331593504
- Cited by
- 112
- References
- 280
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 7 · 2023: 9 · 2022: 18 · 2021: 10 · 2020: 12 · 2019: 12 · 2018: 17 · 2017: 10 · 2016: 3
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Health and Medical Research Council (1055134, 1061044, 1065410)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- class B G protein-coupled receptors, biased agonism, allosteric site, small molecule drug discovery, peptide hormones, osteoporosis, type 2 diabetes, obesity, drug development
- MeSH terms
- Allosteric Regulation, Structure-Activity Relationship, Dimerization, Receptors, G-Protein-Coupled
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.